Chugai Pharmaceutical Co., Ltd. CHGCY Stock
Chugai Pharmaceutical Co., Ltd. Price Chart
Chugai Pharmaceutical Co., Ltd. CHGCY Financial and Trading Overview
| Chugai Pharmaceutical Co., Ltd. stock price | 28.91 USD |
| Previous Close | 14.96 USD |
| Open | 14.85 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 14.65 - 14.85 USD |
| 52 Week Range | 10.99 - 15.11 USD |
| Volume | 27.18K USD |
| Avg. Volume | 74.7K USD |
| Market Cap | 48.63B USD |
| Beta (5Y Monthly) | 0.488888 |
| PE Ratio (TTM) | 21.745588 |
| EPS (TTM) | 0.83 USD |
| Forward Dividend & Yield | 0.29 (1.91%) |
| Ex-Dividend Date | December 29, 2022 |
| 1y Target Est | N/A |
CHGCY Valuation Measures
| Enterprise Value | -505391644672 USD |
| Trailing P/E | 21.745588 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.04013522 |
| Price/Book (mrq) | 0.03385926 |
| Enterprise Value/Revenue | -0.417 |
| Enterprise Value/EBITDA | -1.061 |
Trading Information
Chugai Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.488888 |
| 52-Week Change | 20.21% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 15.11 USD |
| 52 Week Low | 10.99 USD |
| 50-Day Moving Average | 13.2 USD |
| 200-Day Moving Average | 12.73 USD |
CHGCY Share Statistics
| Avg. Volume (3 month) | 74.7K USD |
| Avg. Daily Volume (10-Days) | 44.89K USD |
| Shares Outstanding | 3.29B |
| Float | 1.28B |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.016% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 78 |
| Trailing Annual Dividend Yield | 521.39% |
| 5 Year Average Dividend Yield | 154.00% |
| Payout Ratio | 0.39990002 |
| Last Split Factor | 12:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 26.09% |
| Operating Margin (ttm) | 36.69% |
| Gross Margin | 57.64% |
| EBITDA Margin | 39.30% |
Management Effectiveness
| Return on Assets (ttm) | 16.55% |
| Return on Equity (ttm) | 23.61% |
Income Statement
| Revenue (ttm) | 1.21T USD |
| Revenue Per Share (ttm) | 368.28 USD |
| Quarterly Revenue Growth (yoy) | -13.40% |
| Gross Profit (ttm) | 783.7B USD |
| EBITDA | 476.23B USD |
| Net Income Avi to Common (ttm) | 316.15B USD |
| Diluted EPS (ttm) | 0.68 |
| Quarterly Earnings Growth (yoy) | -44.20% |
Balance Sheet
| Total Cash (mrq) | 554.61B USD |
| Total Cash Per Share (mrq) | 168.56 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.893 |
| Book Value Per Share (mrq) | 436.7195 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 299.32B USD |
| Levered Free Cash Flow (ttm) | 244.3B USD |
Profile of Chugai Pharmaceutical Co., Ltd.
| Country | United States |
| State | N/A |
| City | Chuo |
| Address | 2-1-1 Nihonbashi-Muromachi |
| ZIP | 103-8324 |
| Phone | 81 3 3281 6611 |
| Website | https://www.chugai-pharm.co.jp |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 7771 |
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.
Q&A For Chugai Pharmaceutical Co., Ltd. Stock
What is a current CHGCY stock price?
Chugai Pharmaceutical Co., Ltd. CHGCY stock price today per share is 28.91 USD.
How to purchase Chugai Pharmaceutical Co., Ltd. stock?
You can buy CHGCY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Chugai Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Chugai Pharmaceutical Co., Ltd. is CHGCY.
Which industry does the Chugai Pharmaceutical Co., Ltd. company belong to?
The Chugai Pharmaceutical Co., Ltd. industry is Drug Manufacturers-General.
How many shares does Chugai Pharmaceutical Co., Ltd. have in circulation?
The max supply of Chugai Pharmaceutical Co., Ltd. shares is 3.29B.
What is Chugai Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Chugai Pharmaceutical Co., Ltd. PE Ratio is 34.83132600 now.
What was Chugai Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Chugai Pharmaceutical Co., Ltd. EPS is 0.83 USD over the trailing 12 months.
Which sector does the Chugai Pharmaceutical Co., Ltd. company belong to?
The Chugai Pharmaceutical Co., Ltd. sector is Healthcare.